Cargando…

Societal costs and health related quality of life in adult atopic dermatitis

BACKGROUND: Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary. METHODS: We conducted a multicentre, cross-sectional questionnaire survey betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beretzky, Zsuzsanna, Koszorú, Kamilla, Rencz, Fanni, Hajdu, Krisztina, Borza, Júlia, Bodai, Katalin, Feifei, Xu, Szegedi, Andrea, Sárdy, Miklós, Brodszky, Valentin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426091/ https://www.ncbi.nlm.nih.gov/pubmed/37580792 http://dx.doi.org/10.1186/s12913-023-09840-7

Ejemplares similares

General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Subjective well-being in patients with pemphigus: a path analysis
por: Mitev, Ariel, et al.
Publicado: (2019)

A Rasch model analysis of two interpretations of ‘not relevant’ responses on the Dermatology Life Quality Index (DLQI)
por: Rencz, Fanni, et al.
Publicado: (2021)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
por: Péntek, Márta, et al.
Publicado: (2019)

Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe?
por: Weszl, Miklós, et al.
Publicado: (2019)

Cost-of-illness studies in nine Central and Eastern European countries
por: Brodszky, Valentin, et al.
Publicado: (2019)

A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Geriatrische Dermatologie
por: Joura, Marie Isolde, et al.
Publicado: (2022)

Dermatitis herpetiformis und sonstige Formen der Weizensensitivität
por: Malkovics, T., et al.
Publicado: (2023)

Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index
por: Ruzsa, Gábor, et al.
Publicado: (2022)

Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice
por: Herszényi, Krisztina, et al.
Publicado: (2019)

Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
por: Rencz, Fanni, et al.
Publicado: (2019)

Development the societal preference-based utility value set for the Patient Health Questionnaire depression scale in Hungary
por: Balázs, P., et al.
Publicado: (2022)

Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients
por: Rencz, Fanni, et al.
Publicado: (2021)

A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample
por: Nikl, Anna, et al.
Publicado: (2023)

The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data
por: Baji, Petra, et al.
Publicado: (2020)

Hungarian PROMIS-29+2: psychometric properties and population reference values
por: Jenei, Balázs, et al.
Publicado: (2023)

Societal Costs of Moderate-to-severe Atopic Dermatitis Occurring in Adulthood: A Danish Register-based Study
por: THYSSEN, Jacob P., et al.
Publicado: (2021)

Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters
por: Piros, Éva Anna, et al.
Publicado: (2021)

Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary
por: Angyal, M. Mercédesz, et al.
Publicado: (2023)

Value Set for the EQ-5D-Y-3L in Hungary
por: Rencz, Fanni, et al.
Publicado: (2022)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

Cost of Care of Atopic Dermatitis in India
por: Handa, Sanjeev, et al.
Publicado: (2015)

Quantifying Costs Associated with Atopic Dermatitis
por: Ellis, Charles N., et al.
Publicado: (2003)

EPH99 Determinants of COVID-19 Vaccination in Hungary, Results of a Large Cross-Sectional Online Survey
por: Beretzky, Z, et al.
Publicado: (2022)

Exploring eHealth Literacy and Patient-Reported Experiences With Outpatient Care in the Hungarian General Adult Population: Cross-Sectional Study
por: Zrubka, Zsombor, et al.
Publicado: (2020)

Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies
por: Zrubka, Zsombor, et al.
Publicado: (2019)

The direct and indirect costs of adult atopic dermatitis
por: Manjelievskaia, Janna, et al.
Publicado: (2021)

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data
por: Brodszky, Valentin, et al.
Publicado: (2017)

Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis
por: Sárdy, Miklós, et al.
Publicado: (2002)

Acceptable health and ageing: results of a cross-sectional study from Hungary
por: Péntek, Márta, et al.
Publicado: (2020)

Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis
por: Cabout, Elise, et al.
Publicado: (2020)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e8ulrnqfcu9ags1cmr8qci9lqc